Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 12th August 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EAE vaccine supply issues set to continue
“As a responsible provider, we are actively addressing these issues to minimise the impact on customers” – Roy Geary.
Vaccine won’t be available until October at the earliest.

The Cevac Chlamydia vaccine for enzootic abortion of ewes (EAE) will not be available in September as anticipated, Ceva Animal Health has announced.

The delay to the delivery of the vaccine follows a gap in supply between June and August caused by a batch being out of specification. Ceva Animal Health submitted an Out of Specification request for the vaccine to be released, but the request was not successful.

The next batch may be available in October, but the manufacture has said there is no certainty that it will be.

Last year also saw supply issues with the vaccine, which were blamed on delays in the manufacturing and distribution process.

EAE is one of the most common infectious causes of abortion in ewes. It is estimated to cost the UK sheep industry up to £20 million a year.

Ceva Animal Health has said that it deeply regrets any inconvenience caused to sheep farmers.

Roy Geary, vice-president for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.

“There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.

“As a responsible provider, we are actively addressing these issues to minimise the impact on customers.”

Ceva Animal Health is recommending that veterinary surgeons and farmers follow advice issued by the Sheep Veterinary Society and Sheep Antibiotic Guardian Group which can accessed here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.